Adler S, Sharma R, Savin V J, Abbi R, Eng B
Department of Medicine, New York Medical College, Valhalla, USA.
Am J Pathol. 1996 Sep;149(3):987-96.
Altered glomerular epithelial cell attachment to the glomerular basement membrane is an important pathogenetic factor in increased glomerular permeability to proteins. We have previously presented evidence that antibodies reactive with integrin matrix receptors on glomerular epithelial cells inhibit adhesion of these cells and may be involved in the production of proteinuria in vivo. Therefore, we utilized intact glomeruli in an in vitro system to directly assess the effect of anti-beta 1-integrin antibody on glomerular permeability. Permeability to albumin (Palb) was calculated from the volume response of glomeruli to a transcapillary oncotic gradient. Anti-beta 1-integrin increased Palb in a dose- and time-dependent manner. Palb was increased to 0.70 +/- 0.05 whereas normal rabbit IgG had no effect (0.10 +/- 0.04). F(ab')2 fragments of antibody increased Palb to a similar degree whereas Fab fragments had no effect (0.10 +/- 0.06). Cross-linking of Fab fragments, however, with a second antibody restored their ability to increase Palb (0.60 +/- 0.09), demonstrating the importance of integrin cross-linking in producing the observed effect. Intact, F(ab')2 and Fab fragments of anti-beta 1 antibody all inhibited adhesion of glomerular epithelial cells to fibronectin, laminin, and types I and IV collagen, although the degree of inhibition by Fab fragments was significantly less on collagens. No cytotoxic effects were observed with anti-beta 1 antibody or its fragments. These results suggest that antibodies to integrin matrix receptors on glomerular cells alter cell interactions with the glomerular basement membrane and lead to increased glomerular permeability to proteins via a process that is initiated by integrin cross-linking rather than through simple interference with cell adhesion per se.
肾小球上皮细胞与肾小球基底膜的附着改变是肾小球对蛋白质通透性增加的一个重要致病因素。我们之前已提出证据表明,与肾小球上皮细胞上整合素基质受体反应的抗体可抑制这些细胞的黏附,并可能参与体内蛋白尿的产生。因此,我们在体外系统中利用完整的肾小球直接评估抗β1整合素抗体对肾小球通透性的影响。白蛋白通透性(Palb)根据肾小球对跨毛细血管胶体渗透压梯度的体积反应来计算。抗β1整合素以剂量和时间依赖性方式增加Palb。Palb增加至0.70±0.05,而正常兔IgG无作用(0.10±0.04)。抗体的F(ab')2片段使Palb增加到类似程度,而Fab片段无作用(0.10±0.06)。然而,Fab片段与第二抗体交联后恢复了其增加Palb的能力(0.60±0.09),这表明整合素交联在产生观察到的效应中很重要。抗β1抗体的完整片段、F(ab')2和Fab片段均抑制肾小球上皮细胞与纤连蛋白、层粘连蛋白以及I型和IV型胶原的黏附,尽管Fab片段对胶原的抑制程度明显较小。抗β1抗体及其片段未观察到细胞毒性作用。这些结果表明,针对肾小球细胞上整合素基质受体的抗体改变了细胞与肾小球基底膜的相互作用,并通过由整合素交联启动而非简单干扰细胞黏附本身的过程导致肾小球对蛋白质的通透性增加。